Mid-Year Report

AMERICAN PHARMACISTS ASSOCIATION for AMERICAN PHARMACISTS ASSOCIATION

Firm
Client
Income
—
Expenses
$374,162

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Specifi to Labor/HHS funding, AHRQ comparative cost-effectiveness funding, and the National Immunization Program at the Centers for Disease Control and Prevention. H.J. Res 20 Making further continuing appropriations for the fiscal year 2007 FY 2008 Labor, Health and Human Services and Education Appropriations Bill.

LobbyistCovered position, as disclosed
MARCIE BOUGH N/A
HRANT JAMGOCHIAN N/A
KRISTINA E LUNNER N/A
CATHERINE POLLEY N/A

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.J.Res. 20 (110th)

Pharmacy PHA

H.R. 2900 the FDA Amendments Act of 2007 S. 1082 FDA Revitalization Act Prescription Drug Importation S. 184 the Safe IMPORT Act S. 242 the Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251 the Pharmaceutical Market Access Act of 2007 Senate Amendment 1010 to S. 1082 re prescription drug importation Internet Pharmacy S. 596 the Safe Internet Pharmacy Act of 2007 FDA Docket No. 2007N-0121 re: Medication Guides (MedGuides) S. 1695 Biologics Price Competition and Innovation Act of 2007 FDA Docket No. 2007N-0114 re: Electronic distribution of prescription information FDA Docket No. 2007N-0179 re: Risk Minimization Action Plans (RiskMAPs) Authorized generics Follow-on Biologics HRSA Docket E7–334 – Multiple contract pharmacies re: 340B Drug Pricing Program-Contract Pharmacy Services HRSA Docket E7–335 – Patient definition re: 340B Drug Pricing Program Patient Definition FDA Docket No. 2007D–0101 – Draft guidance on advisory committee member conflicts of interest FDA Docket No. 1977N-0094L, RIN 0910-AF36 re: changes to the warnings and other labeling for over-the-counter analgesie drug products Pharmacy Compounding Draft bill, the Safe Drug Compounding Act of 2007 Bioidentical Hormones FDA Docket 2007N-0005 re: recommendations for the Prescription Drug User Fee Act (PDUFA)

LobbyistCovered position, as disclosed
MARCIE BOUGH N/A
HRANT JAMGOCHIAN N/A
KRISTINA E LUNNER N/A
CATHERINE POLLEY N/A

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); SENATE

Bills named: S. 251 (110th), S. 242 (110th), S. 184 (110th), S. 1082 (110th), S. 1695 (110th), H.R. 2900 (110th), S. 596 (110th)

Health Issues HCR

ONC re: comments on the medication management draft detailed use case and patient medication and allergy information exchange between consumers and health care provider. H.R. 2184 the Enhanced Health Care Value for All Act of 2007 H.R. 2994 the National Pain Care Policy Act of 2007 Immunization distribution

LobbyistCovered position, as disclosed
MARCIE BOUGH N/A
HRANT JAMGOCHIAN N/A
KRISTINA E LUNNER N/A
CATHERINE POLLEY N/A

Contacted: Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 2994 (110th), H.R. 2184 (110th)

Medicare/Medicaid MMM

H.R. 4 the Medicare Prescription Drug Price Negotiation Act of 2007 S. 3 the Medicare Prescription Drug Price Negotiation Act of 2007 H.R. 1474 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007' Medicaid reimbursement for pharmacy Medicare - specific to vaccine administration Medicare – specific to the durable medical equipment prosthetics, orthotics, and supplies (DMEPOS)competitive bidding program Medicare – specific to payments for Epogen and reimbursement issues for the treatment of End Stage Renal Disease (ESRD). H.R. 3162 to reauthorize the State Children's Health Insurance Program (SCHIP) - Medicare related items President's 2008 budget – specific to pharmacy reimbursement in Medicaid CMS Docket CMS-2238-P/RIN 0938–AO20 re: Medicaid Program; Prescription Drugs - implementation of the Deficit Reduction Act of 2005 and AMP CMS Docket No. CMS-4124-P re: proposed Medicare Part D technical amendments. H.R. 3090 - Patient and Pharmacy Protection Act of 2007 S. 2013- Patient and Pharmacy Protection Act of 2007 Medicare Part D Prescription Drug Benefit - pharmacy issues Medication Therapy Management Services CMS re: Draft 2008 Part D Plan Call Letter Tamper-Resistant Prescription Pad Requirement in Medicaid

LobbyistCovered position, as disclosed
MARCIE BOUGH N/A
HRANT JAMGOCHIAN N/A
KRISTINA E LUNNER N/A
CATHERINE POLLEY N/A

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 3 (110th), H.R. 1474 (110th), H.R. 3162 (110th), S. 2013 (110th), H.R. 4 (110th), H.R. 3090 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.